16600554

Source:http://linkedlifedata.com/resource/pubmed/id/16600554

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023281, umls-concept:C0061366, umls-concept:C0087111, umls-concept:C0221912, umls-concept:C0879626, umls-concept:C1512954
pubmed:issue	4
pubmed:dateCreated	2006-5-8
pubmed:abstractText	The treatment of cutaneous leishmaniasis used in Tunisia is Glucantime. The aim of this retrospective study was to determine the adverse effects of intralesional Glucantime and to calculate the risk/benefit rate of this treatment.
pubmed:language	fre
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0311416
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiprotozoal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Meglumine, http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds, http://linkedlifedata.com/resource/pubmed/chemical/meglumine antimoniate
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0399-077X
pubmed:author	pubmed-author:BoudayaSS, pubmed-author:MaalejNN, pubmed-author:MasmoudiAA, pubmed-author:TurkiHH, pubmed-author:ZahafAA
pubmed:issnType	Print
pubmed:volume	36
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	226-8
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16600554-Adolescent, pubmed-meshheading:16600554-Adult, pubmed-meshheading:16600554-Antiprotozoal Agents, pubmed-meshheading:16600554-Child, pubmed-meshheading:16600554-Disease Susceptibility, pubmed-meshheading:16600554-Drug Eruptions, pubmed-meshheading:16600554-Facial Dermatoses, pubmed-meshheading:16600554-Female, pubmed-meshheading:16600554-Humans, pubmed-meshheading:16600554-Injections, Intralesional, pubmed-meshheading:16600554-Leishmaniasis, Cutaneous, pubmed-meshheading:16600554-Male, pubmed-meshheading:16600554-Meglumine, pubmed-meshheading:16600554-Middle Aged, pubmed-meshheading:16600554-Organometallic Compounds, pubmed-meshheading:16600554-Retrospective Studies, pubmed-meshheading:16600554-Risk Assessment, pubmed-meshheading:16600554-Sporotrichosis, pubmed-meshheading:16600554-Staphylococcal Skin Infections, pubmed-meshheading:16600554-Superinfection
pubmed:year	2006
pubmed:articleTitle	[Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis].
pubmed:affiliation	Service de Dermatologie, EPS Hédi-Chaker, CHU Hédi-Chaker, 3029 Sfax, Tunisie. masmoudiabd@yahoo.fr
pubmed:publicationType	Journal Article, English Abstract